News - Zdravlje Leskovac - Pharmaceutical and Chemicstry industry


Untitled-design-16-1280x665.png
07/10/2024

Zdravlje recently completed a comprehensive six-day inspection by the European Medicines Authority from September 5-10, concluding successfully with zero critical observations. Recognized with the prestigious EU GMP certification since 2009, our facility continues to uphold full compliance and excellence in quality, innovation, and trust.

Leading-the-Way-1280x855.png
05/09/2024

As part of our new series, Leading The Way, we are proud to bring you exclusive insights from the leaders who are shaping the future of Zdravlje. In each interview, weโ€™ll dive into their unique perspectives, key experiences, and the strategies they employ to drive our company forward. Through these conversations, we aim to highlight the vision, innovation, and leadership that have defined Zdravlje for decades. In this first interview, we sit down with Dusan Cvetanovic, Senior Site Director, to explore his journey and his thoughts on the future of our industry.

Untitled-design-16-1280x763.png
28/08/2024

We are proud to announce that Zdravlje has been ๐—ฐ๐—ฒ๐—ฟ๐˜๐—ถ๐—ณ๐—ถ๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—˜๐—ฐ๐—ผ๐—ฉ๐—ฎ๐—ฑ๐—ถ๐˜€, an independent ๐—ด๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ฟ ๐—ผ๐—ณ ๐—ฏ๐˜‚๐˜€๐—ถ๐—ป๐—ฒ๐˜€๐˜€ ๐˜€๐˜‚๐˜€๐˜๐—ฎ๐—ถ๐—ป๐—ฎ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐˜† ๐—ฟ๐—ฎ๐˜๐—ถ๐—ป๐—ด๐˜€, placing us in the ๐˜๐—ผ๐—ฝ ๐Ÿฏ๐Ÿฑ% ๐—ผ๐—ณ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ assessed globally for sustainability! This recognition is especially significant as it follows our first audit in the ESG field. EcoVadis, a globally respected sustainability ratings provider, evaluates companies based on 21 sustainability criteria, including environmental impact, labor and human rights, ethics, and sustainable procurement.

BIO4-campus.jpg
28/12/2023

We are excited to announce Serbia's commencement of constructing the BIO4 campus in Belgrade! This campus is set to become a central hub for innovation, research and collaboration, uniting brilliant minds with cutting-edge technologies. As Zdravlje, we are honoured to play a role in this ground-breaking project, poised to redefine the biotechnology landscape in Europe. Our commitment is to pioneer the development of novel biologics for the prevention and treatment of life-threatening diseases.

Zdravlje-PKS-1280x960.jpg
15/12/2023

The successful and long-term business of Zdravlje was also recognized by the Chamber of Commerce of Serbia (PKS). At the premises of the Regional Chamber of Commerce (RPK) in Leskovac, during the ceremonial session of the Parliament of Businessmen, Zdravlje was presented with the JUBILEE AWARD OF THE CHAMBER OF COMMERCE OF SERBIA for 70 years of successful business.

zdravlje-leskovac-70-years-celebrate-2.jpg
25/11/2023

Zdravlje Leskovac ceremoniously marked a significant milestone - seven decades of dedication to innovation, trust, and quality. The celebration, held on Friday, November 24, brought together more than 350 guests, including our business partners, collaborators, and representatives of institutions who, along with our employees, reminisced about the extensive history of Zdravlje.

pilula.jpeg
10/11/2023

Zdravlje/Frontier Biopharma has received another Marketing Authorisation in the CEE issued by the Bulgarian Drug Agency for PazoFrontยฎ 200mg and 400mg, film-coated tablets (INN: pazopanib). PazoFrontโ€™s active substance (pazopanib) is a protein kinase inhibitor that works by preventing the activity of proteins involved in the growth and spread of cancer cells.

Kiren-ceo-biotech-future.jpg
19/10/2023

To mark this weekโ€™s second Biotech Future Forum in Belgrade, our CEO, Kiren L. Naidoo, reaffirms Zdravljeโ€™s commitment to building the biotechnology industry in Serbia. Through valuable partnerships with the Government of the Republic of Serbia, academia, and leading international partners, Frontier Biopharma and Zdravlje are set to lead the biotechnology industry in the region across critical areas such as next-generation vaccines, cell & gene therapies โ€“ all domestically produced and intended to serve patients locally and abroad.

logo-zdravlje-blog-news.jpg
18/08/2023

Zdravlje is pleased to announce that as of 16 August 2023, Dragana Grujic Stosic has joined Zdravljeโ€™s Commercial team as a Marketing Manager. She will be responsible for leading our product managers team and building our strategic marketing expertise to ensure the targeted growth. Dragana will report directly to Dmitriy Sovetkin, Commercial Director.

industrial

Contact


+381 60 790 2200

Vlajkova St. 199, 16000 Leskovac, SerbiaMilutina Milankovica Blvd. 23, Belgrade, Serbia

info@zdravlje.co.rs